Improving imaging techniques for detecting eye changes in neurodegenerative diseases
Achieving specificity in imaging neurodegeneration with visible light Optical Coherence Tomography
This study is working on a new way to take clearer pictures of the retina to help doctors better understand how diseases like Alzheimer's and Parkinson's affect vision, which could lead to better ways to track and treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11096252 on NIH RePORTER |
What this research studies
This research focuses on enhancing imaging technology to better visualize changes in the retina associated with neurodegenerative diseases like Alzheimer's and Parkinson's. By developing a new type of optical coherence tomography (OCT) that uses visible light, the researchers aim to achieve higher resolution images of the retina, which can reveal important biomarkers for disease progression. The study will also incorporate machine learning tools to analyze the imaging data, providing a more detailed understanding of how these diseases affect the visual system. This could lead to improved monitoring and treatment strategies for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or Parkinson's disease who are experiencing visual system changes.
Not a fit: Patients with neurodegenerative diseases who do not exhibit any ocular symptoms or changes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of neurodegenerative diseases through improved retinal imaging.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for understanding neurodegenerative diseases, indicating that this approach could yield valuable insights.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Srinivasan, Vivek Jay — New York University School of Medicine
- Study coordinator: Srinivasan, Vivek Jay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.